PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation - Wikidata - awgldk - TriplyDB

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

http://www.wikidata.org/entity/Q28168772

about

Resistance to antiplatelet drugs: current status and future research Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease Pro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606.Clopidogrel "resistance": where are we now?Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials.Genetics of coagulation: considerations for cardiac surgery.Pharmacogenomics of platelet responsiveness to aspirin.CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors Pharmacogenetics of cardiovascular drug therapy.Pharmacogenetics guided anticoagulation.A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?The pharmacogenetics of antiplatelet agents: towards personalized therapy?The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.Pharmacogenomics in cardiovascular disease: focus on aspirin and ADP receptor antagonists.The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.Pharmacogenomics of oral antiplatelet drugs.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention.Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population Platelet aggregation pathway.Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke.Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke.Prevalence of CYP2C19 polymorphisms in the Lebanese population.The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

P2860

Q28192298-89F50A78-3039-4EE4-9465-0D1D67A91549 Q28196714-0339E109-3F84-41B9-B6CC-FCB8D629C5AB Q28211198-DF501C6D-2A68-4CA1-A0C6-F3D8A09FB1A8 Q33584613-7A26BF19-844E-4AFD-9734-E88CDCC4E011 Q34212563-95AD2E01-ED95-42D6-B50C-2477D3E8DEB6 Q34994015-2C81A577-1E7E-496D-A907-DD497404AE9B Q36697910-99C28B1A-1E59-4530-90F2-E2E9267C263D Q36989841-2D265C99-701F-4B85-940C-A5AE4886E0E0 Q37140633-7F34BF8B-7DFC-4CD5-A380-48B77B0E2C27 Q37430401-B9D54975-C658-44AF-ADBD-079B4F816339 Q37808224-0FBD13A4-121B-4D95-9FE3-B7DE2E3CD4E2 Q37908891-F7B565C5-BC3B-4A7D-BD25-9C5B37DF55E5 Q37913976-5DF4973B-34A8-4BA4-82EB-4FB1C04005EE Q37923969-28B9758B-D42E-4129-B1D2-2C0C101360CB Q38117748-0D511FEA-6EE8-4359-91FF-984CFDDA4A1C Q38120047-414251DF-106D-40E0-BD9B-49FB02E5400E Q38195628-8710AF0A-DFE2-4462-A6E8-3C584B4A62A5 Q38307535-373C87F0-6248-4484-8829-9E313785F5BD Q38401281-59704844-158A-4CEA-93EB-F1821BC1046B Q42378480-73A8AC9F-2846-43E6-8AAE-FF90386DE3FF Q42796609-09B5A13C-E072-487B-ADD3-BDB436BC2C94 Q44473132-C575A679-D054-473C-A4E4-294A6C257FB9 Q45710707-BCD2FE43-BE34-474B-827A-0F921B19AD38 Q48355548-43455B83-5EFB-4421-AFE7-1BAAA22A9B04 Q53584028-B854B276-5856-4004-9372-7A582F6F3554 Q53783676-C3C18431-211A-462F-9C23-FCC079793255 Q54384410-1872314B-581C-4675-A3F4-740199B80F31 Q54627886-1D41F155-96A2-45E4-9DD5-B3B0953A8545

P2860

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

http://www.wikidata.org/entity/Q28168772

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

PlA polymorphism and platelet ...... ng coronary stent implantation

@ast

PlA polymorphism and platelet ...... ng coronary stent implantation

@en

PlA polymorphism and platelet ...... ng coronary stent implantation

@nl

type

label

PlA polymorphism and platelet ...... ng coronary stent implantation

@ast

PlA polymorphism and platelet ...... ng coronary stent implantation

@en

PlA polymorphism and platelet ...... ng coronary stent implantation

@nl

prefLabel

PlA polymorphism and platelet ...... ng coronary stent implantation

@ast

PlA polymorphism and platelet ...... ng coronary stent implantation

@en

PlA polymorphism and platelet ...... ng coronary stent implantation

@nl

P1433

Q28168772-B4BB7A71-D2B5-4B47-AFA5-909D3427E2A9

P1476

Q28168772-6273183A-0D77-40F5-829B-D5040F35CA4D

P2093

Q28168772-0E29FC76-05BA-4CB4-B8F1-C712E5C2BEEE

Q28168772-2E5665D6-B184-47A5-955E-14DB6F9AE43D

Q28168772-3B57AA12-82AA-4FB4-856B-CE322F03C2D0

Q28168772-45BBA77B-8F3B-4B62-9459-5F38CE32FE32

Q28168772-4A45F0BD-071C-4CB0-B876-516281B3F6EF

Q28168772-53E82DDF-8D5F-44D1-9283-4C373DA6940B

Q28168772-62623B71-C46E-4B57-A973-0A32B3ACAFF7

Q28168772-C0E1A78D-09C7-4EFA-8D3B-F686D936E9EE

Q28168772-C2A7516A-638A-43F3-8BD2-4B7F5799FE56

Q28168772-EB9E5FF0-18D9-4DBB-8BB4-1E10EA25DBD1

P304

Q28168772-8A653FC6-76DF-478A-9C18-9B87CF38F961

P31

Q28168772-8AAF9D58-34FE-4E67-8E2E-C13CD39B7EED

P356

Q28168772-BF319125-9C2C-48CC-926C-2B114E5CB4CF

P407

Q28168772-3400A8D8-9B28-4524-BD83-F6B1C24485BC

P433

Q28168772-F5CFAFFA-741D-4365-AAE6-BDFAE0B86D28

P478

Q28168772-20FF695E-B418-48E7-8F6A-2995B34BBA6D

P577

Q28168772-52D74E2A-2E5A-429C-A6AD-E54C38EFDD43

P698

Q28168772-AD2DF080-B3CA-489F-B1E3-5E29E4AE469A

P921

Q28168772-77EC446E-34F2-42A8-A22B-B8832F658EFE

P356

00001721-200401000-00014

P1433

Blood Coagulation and Fibrinolysis

P1476

PlA polymorphism and platelet ...... ng coronary stent implantation

@en

P2093

Antonio Fernandez-Ortiz

http://www.w3.org/2001/XMLSchema#string

Carlos Macaya

http://www.w3.org/2001/XMLSchema#string

Chiara Stranieri

http://www.w3.org/2001/XMLSchema#string

Cristina Fernández

http://www.w3.org/2001/XMLSchema#string

Dominick J Angiolillo

http://www.w3.org/2001/XMLSchema#string

Elisabetta Trabetti

http://www.w3.org/2001/XMLSchema#string

Esther Bernardo

http://www.w3.org/2001/XMLSchema#string

Fernando Alfonso

http://www.w3.org/2001/XMLSchema#string

Manel Sabaté

http://www.w3.org/2001/XMLSchema#string

Pier Franco Pignatti

http://www.w3.org/2001/XMLSchema#string

P304

89-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00001721-200401000-00014

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15166949

http://www.w3.org/2001/XMLSchema#string

P921